Michael Krainer

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.

Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.

Journal: Nature communications

Published: July 25, 2025

Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer.

Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer.

Journal: Clinical & experimental metastasis

Published: July 03, 2024

Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer.

Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer.

Journal: Cancers

Published: January 31, 2023

Current Developments in Cellular Therapy for Castration Resistant Prostate Cancer: A Systematic Review of Clinical Studies.

Current Developments in Cellular Therapy for Castration Resistant Prostate Cancer: A Systematic Review of Clinical Studies.

Journal: Cancers

Published: September 14, 2022

Comparison of microfluidic platforms for the enrichment of circulating tumor cells in breast cancer patients.

Comparison of microfluidic platforms for the enrichment of circulating tumor cells in breast cancer patients.

Journal: Breast cancer research and treatment

Published: June 30, 2022

MALAT1 Fusions and Basal Cells Contribute to Primary Resistance against Androgen Receptor Inhibition in TRAMP Mice.

MALAT1 Fusions and Basal Cells Contribute to Primary Resistance against Androgen Receptor Inhibition in TRAMP Mice.

Journal: Cancers

Published: July 21, 2021

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions.

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions.

Journal: Journal of visualized experiments : JoVE

Published: June 14, 2021

The prostate cancer landscape in Europe: Current challenges, future opportunities.

The prostate cancer landscape in Europe: Current challenges, future opportunities.

Journal: Cancer letters

Published: March 12, 2021

Erratum to 'Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database' [European Journal of Cancer, Volume 125 (January 2020) Pages 153-163].

Erratum to 'Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database' [European Journal of Cancer, Volume 125 (January 2020) Pages 153-163].

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 30, 2020

Corrigendum to "Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database" [Eur J Canc 125, (January 2020) 153-163].

Corrigendum to "Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database" [Eur J Canc 125, (January 2020) 153-163].

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 02, 2020

Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field.

Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field.

Journal: ESMO open

Published: June 24, 2020

Loss of HCRP1 leads to upregulation of PD-L1 via STAT3 activation and is of prognostic significance in EGFR-dependent cancer.

Loss of HCRP1 leads to upregulation of PD-L1 via STAT3 activation and is of prognostic significance in EGFR-dependent cancer.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: April 28, 2020

Showing 1-12 of 47

Last Updated: 09/26/2026